AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
FREQUENT DEREGULATION OF P16 AND THE P16 G(1) CELL CYCLE-REGULATORY PATHWAY IN NEUROBLASTOMA/
Authors: DICCIANNI MB OMURAMINAMISAWA MO BATOVA A LE T BRIDGEMAN L YU AL
Citation: Mb. Diccianni et al., FREQUENT DEREGULATION OF P16 AND THE P16 G(1) CELL CYCLE-REGULATORY PATHWAY IN NEUROBLASTOMA/, International journal of cancer, 80(1), 1999, pp. 145-154
PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA
Authors: YU AL UTTENREUTHERFISCHER MM HUANG CS TSUI CC GILLIES SD REISFELD RA KUNG FH
Citation: Al. Yu et al., PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA, Journal of clinical oncology, 16(6), 1998, pp. 2169-2180
PRESENCE OF METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) IN HEMATOPOIETICSTEM PROGENITOR CELLS - ITS THERAPEUTIC IMPLICATION FOR MTAP (-) MALIGNANCIES/
Authors: YU J BATOVA A SHAO LE CARRERA CJ YU AL
Citation: J. Yu et al., PRESENCE OF METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) IN HEMATOPOIETICSTEM PROGENITOR CELLS - ITS THERAPEUTIC IMPLICATION FOR MTAP (-) MALIGNANCIES/, Clinical cancer research, 3(3), 1997, pp. 433-438
AN ANIMAL-MODEL OF PAIN PRODUCED BY SYSTEMIC ADMINISTRATION OF AN IMMUNOTHERAPEUTIC ANTIGANGLIOSIDE ANTIBODY
Authors: SLART R YU AL YAKSH TL SORKIN LS
Citation: R. Slart et al., AN ANIMAL-MODEL OF PAIN PRODUCED BY SYSTEMIC ADMINISTRATION OF AN IMMUNOTHERAPEUTIC ANTIGANGLIOSIDE ANTIBODY, Pain, 69(1-2), 1997, pp. 119-125
ELECTROPHYSIOLOGICAL CHARACTERISTICS OF PRIMARY AFFERENT-FIBERS AFTERSYSTEMIC ADMINISTRATION OF ANTI-GD2 GANGLIOSIDE ANTIBODY
Authors: XIAO WH YU AL SORKIN LS
Citation: Wh. Xiao et al., ELECTROPHYSIOLOGICAL CHARACTERISTICS OF PRIMARY AFFERENT-FIBERS AFTERSYSTEMIC ADMINISTRATION OF ANTI-GD2 GANGLIOSIDE ANTIBODY, Pain, 69(1-2), 1997, pp. 145-151
SHORTENED SURVIVAL AFTER RELAPSE IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS WITH P16 P15 DELETIONS/
Authors: DICCIANNI MB BATOVA A YU J VU T PULLEN J AMYLON M POLLOCK BH YU AL
Citation: Mb. Diccianni et al., SHORTENED SURVIVAL AFTER RELAPSE IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS WITH P16 P15 DELETIONS/, Leukemia research, 21(6), 1997, pp. 549-558
P16(INK4) AND P15(INK4B) ALTERATIONS IN PRIMARY GYNECOLOGIC MALIGNANCY
Authors: WONG YF CHUNG TKH CHEUNG TH NOBORI T YIM SF LAI KWH YU AL DICCIANNI MB LI TZ CHANG AMZ
Citation: Yf. Wong et al., P16(INK4) AND P15(INK4B) ALTERATIONS IN PRIMARY GYNECOLOGIC MALIGNANCY, Gynecologic oncology, 65(2), 1997, pp. 319-324
FREQUENT AND SELECTIVE METHYLATION OF P15 AND DELETION OF BOTH P15 AND P16 IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: BATOVA A DICCIANNI MB YU JC NOBORI T LINK MP PULLEN J YU AL
Citation: A. Batova et al., FREQUENT AND SELECTIVE METHYLATION OF P15 AND DELETION OF BOTH P15 AND P16 IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, Cancer research, 57(5), 1997, pp. 832-836
INACTIVATION OF P16 CELL-CYCLE REGULATORY PATHWAY BY SPECIFIC TARGETING OF P16 BUT NOT THE DOWNSTREAM COMPONENTS IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (T-ALL) - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: OMURAMINAMISAWA M DICCIANNI MB BATOVA A PULLEN J BOWMAN WP YU AL
Citation: M. Omuraminamisawa et al., INACTIVATION OF P16 CELL-CYCLE REGULATORY PATHWAY BY SPECIFIC TARGETING OF P16 BUT NOT THE DOWNSTREAM COMPONENTS IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (T-ALL) - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Blood, 90(10), 1997, pp. 2190-2190
LOCALIZATION AND REGULATION BY VITAMIN-D OF CALCIUM-TRANSPORT PROTEINS IN RABBIT CORTICAL COLLECTING SYSTEM
Authors: VANBAAL J YU AL HARTOG A FRANSEN JAM WILLEMS PHGM LYTTON J BINDELS RJM
Citation: J. Vanbaal et al., LOCALIZATION AND REGULATION BY VITAMIN-D OF CALCIUM-TRANSPORT PROTEINS IN RABBIT CORTICAL COLLECTING SYSTEM, American journal of physiology. Renal, fluid and electrolyte physiology, 40(5), 1996, pp. 985-993
THE P16 AND P18 TUMOR-SUPPRESSOR GENES IN NEUROBLASTOMA - IMPLICATIONS FOR DRUG-RESISTANCE
Authors: DICCIANNI MB CHAU LS BATOVA A VU TQ YU AL
Citation: Mb. Diccianni et al., THE P16 AND P18 TUMOR-SUPPRESSOR GENES IN NEUROBLASTOMA - IMPLICATIONS FOR DRUG-RESISTANCE, Cancer letters, 104(2), 1996, pp. 183-192
ANTIBODY-DIRECTED PHAGOCYTOSIS OF TUMOR-CELLS IS ENHANCED BY IL-1-BETA AND M-CSF IN FRESHLY ISOLATED HUMAN MONOCYTES OF THE NEW MACROPHAGE LINE K1M
Authors: LEE MJ DIALYNAS DP SHAO LE YU AL YU J
Citation: Mj. Lee et al., ANTIBODY-DIRECTED PHAGOCYTOSIS OF TUMOR-CELLS IS ENHANCED BY IL-1-BETA AND M-CSF IN FRESHLY ISOLATED HUMAN MONOCYTES OF THE NEW MACROPHAGE LINE K1M, Experimental hematology, 24(9), 1996, pp. 269-269
EXPLOITATION OF FREQUENT DELETION IN THE METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) GENE IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC (T-ALL)
Authors: YU J BATOVA A SHAO LE YU AL
Citation: J. Yu et al., EXPLOITATION OF FREQUENT DELETION IN THE METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) GENE IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC (T-ALL), Experimental hematology, 24(9), 1996, pp. 544-544
FREQUENT DELETION IN THE METHYLTHIOADENOSINE PHOSPHORYLASE GENE IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - STRATEGIES FOR ENZYME-TARGETED THERAPY
Authors: BATOVA A DICCIANNI MB NOBORI T VU T YU J BRIDGEMAN L YU AL
Citation: A. Batova et al., FREQUENT DELETION IN THE METHYLTHIOADENOSINE PHOSPHORYLASE GENE IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - STRATEGIES FOR ENZYME-TARGETED THERAPY, Blood, 88(8), 1996, pp. 3083-3090
PREFERENTIAL INACTIVATION OF P15(INK4B) BUT NOT P16(INK4A) BY HYPERMETHYLATION IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: YU AL BATOVA A DICCIANNI MB PULLEN J LINK MP YU J
Citation: Al. Yu et al., PREFERENTIAL INACTIVATION OF P15(INK4B) BUT NOT P16(INK4A) BY HYPERMETHYLATION IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 1408-1408
IFOSFAMIDE CARBOPLATIN ETOPOSIDE (ICE) FOR RECURRENT MALIGNANT SOLID TUMORS OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP PHASE I II STUDY/
Authors: KUNG FH DESAI SJ DICKERMAN JD GOORIN AM HARRIS MB INOUE S KRISCHER JP MURPHY SB PRATT CB TOLEDANO S WILEY JM YU AL
Citation: Fh. Kung et al., IFOSFAMIDE CARBOPLATIN ETOPOSIDE (ICE) FOR RECURRENT MALIGNANT SOLID TUMORS OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP PHASE I II STUDY/, Journal of pediatric hematology/oncology, 17(3), 1995, pp. 265-269
PHARMACOKINETICS OF HUMAN-MOUSE CHIMERIC ANTI-GD2 MAB CH14.18 IN A PHASE-I TRIAL IN NEUROBLASTOMA PATIENTS
Authors: UTTENREUTHERFISCHER MM HUANG CS YU AL
Citation: Mm. Uttenreutherfischer et al., PHARMACOKINETICS OF HUMAN-MOUSE CHIMERIC ANTI-GD2 MAB CH14.18 IN A PHASE-I TRIAL IN NEUROBLASTOMA PATIENTS, Cancer immunology and immunotherapy, 41(6), 1995, pp. 331-338
PHARMACOKINETICS OF ANTIGANGLIOSIDE GD2 MAB 14G2A IN A PHASE-I TRIAL IN PEDIATRIC CANCER-PATIENTS
Authors: UTTENREUTHERFISCHER MM HUANG CS REISFELD RA YU AL
Citation: Mm. Uttenreutherfischer et al., PHARMACOKINETICS OF ANTIGANGLIOSIDE GD2 MAB 14G2A IN A PHASE-I TRIAL IN PEDIATRIC CANCER-PATIENTS, Cancer immunology and immunotherapy, 41(1), 1995, pp. 29-36
HIGH-FREQUENCY ALTERATIONS OF THE P16 AND P15, BUT NOT P18, CDK INHIBITORS IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: YU AL DICCIANNI MB BATOVA A VU T PULLEN J AMYLON M POLLOCK B YU J
Citation: Al. Yu et al., HIGH-FREQUENCY ALTERATIONS OF THE P16 AND P15, BUT NOT P18, CDK INHIBITORS IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 86(10), 1995, pp. 1057-1057
PSEUDOTYPED RETROVIRAL VECTOR-MEDIATED GENE-TRANSFER INTO HUMAN LEUKEMIC-CELLS
Authors: BURNS JC LOZINSKI GM YEE JK FRIEDMANN T YU J YU AL
Citation: Jc. Burns et al., PSEUDOTYPED RETROVIRAL VECTOR-MEDIATED GENE-TRANSFER INTO HUMAN LEUKEMIC-CELLS, Pediatric research, 35(4), 1994, pp. 10000158-10000158
PSEUDOTYPED RETROVIRAL VECTOR-MEDIATED GENE-TRANSFER INTO HUMAN LEUKEMIC-CELLS
Authors: LOZINSKI GM YU AL YEE JK FRIEDMANN T BURNS JC
Citation: Gm. Lozinski et al., PSEUDOTYPED RETROVIRAL VECTOR-MEDIATED GENE-TRANSFER INTO HUMAN LEUKEMIC-CELLS, Clinical research, 42(1), 1994, pp. 10000056-10000056
CLINICAL-SIGNIFICANCE OF P53 MUTATIONS IN RELAPSED T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: DICCIANNI MB YU J HSIAO M MUKHERJEE S SHAO LE YU AL
Citation: Mb. Diccianni et al., CLINICAL-SIGNIFICANCE OF P53 MUTATIONS IN RELAPSED T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 84(9), 1994, pp. 3105-3112
CLINICAL-SIGNIFICANCE OF P53 MUTATIONS IN RELAPSED T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: DICCIANNI MB YU J HSIAO M MUKHERJEE S SHAO LE YU AL
Citation: Mb. Diccianni et al., CLINICAL-SIGNIFICANCE OF P53 MUTATIONS IN RELAPSED T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 84(9), 1994, pp. 3105-3112
NONHEREDITARY P53 MUTATIONS IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA ARE ASSOCIATED WITH THE RELAPSE PHASE
Authors: HSIAO MH YU AL YEARGIN J KU D HAAS M
Citation: Mh. Hsiao et al., NONHEREDITARY P53 MUTATIONS IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA ARE ASSOCIATED WITH THE RELAPSE PHASE, Blood, 83(10), 1994, pp. 2922-2930
P53 MUTATION IN ACUTE T-CELL LYMPHOBLASTIC-LEUKEMIA IS OF SOMATIC ORIGIN AND IS STABLE DURING ESTABLISHMENT OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES
Authors: YEARGIN J CHENG J YU AL GJERSET R BOGART M HAAS M
Citation: J. Yeargin et al., P53 MUTATION IN ACUTE T-CELL LYMPHOBLASTIC-LEUKEMIA IS OF SOMATIC ORIGIN AND IS STABLE DURING ESTABLISHMENT OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES, The Journal of clinical investigation, 91(5), 1993, pp. 2111-2117
Risultati: 1-25 | 26-26